首页> 外文期刊>Bone research >The biological function of type I receptors of bone morphogenetic protein in bone
【24h】

The biological function of type I receptors of bone morphogenetic protein in bone

机译:骨中骨形态发生蛋白I型受体的生物学功能

获取原文
       

摘要

Bone morphogenetic proteins (BMPs) have multiple roles in skeletal development, homeostasis and regeneration. BMPs signal via type I and type II serine/threonine kinase receptors (BMPRI and BMPRII). In recent decades, genetic studies in humans and mice have demonstrated that perturbations in BMP signaling via BMPRI resulted in various diseases in bone, cartilage, and muscles. In this review, we focus on all three types of BMPRI, which consist of activin-like kinase 2 (ALK2, also called type IA activin receptor), activin-like kinase 3 (ALK3, also called BMPRIA), and activin-like kinase 6 (ALK6, also called BMPRIB). The research areas covered include the current progress regarding the roles of these receptors during myogenesis, chondrogenesis, and osteogenesis. Understanding the physiological and pathological functions of these receptors at the cellular and molecular levels will advance drug development and tissue regeneration for treating musculoskeletal diseases and bone defects in the future.
机译:骨形态发生蛋白(BMP)在骨骼发育,体内稳态和再生中具有多种作用。 BMP通过I型和II型丝氨酸/苏氨酸激酶受体(BMPRI和BMPRII)发出信号。近几十年来,对人类和小鼠进行的遗传研究表明,通过BMPRI对BMP信号的干扰会导致骨骼,软骨和肌肉的各种疾病。在这篇综述中,我们重点介绍所有三种类型的BMPRI,包括激活素样激酶2(ALK2,也称为IA型激活素受体),激活素样激酶3(ALK3,也称为BMPRIA)和激活素样激酶6(ALK6,也称为BMPRIB)。涵盖的研究领域包括有关这些受体在肌发生,软骨形成和成骨过程中的作用的最新进展。在细胞和分子水平上了解这些受体的生理和病理学功能将促进药物开发和组织再生,从而在将来治疗肌肉骨骼疾病和骨缺损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号